HealthQuill Articles by: HealthQuill
Germany’s BioNTech SE will acquire CureVac N.V., which develops therapies based on messenger RNA, for $1.25 billion in an all-stock deal to expand the former’s mRNA-based cancer immunotherapy candidates.
Drugs Health Pharma

BioNTech SE to acquire CureVac for $1.25 billion in all-stock deal

HQ Team June 12, 2025: Germany’s BioNTech SE will acquire CureVac N.V., which develops therapies based on messenger RNA, for $1.25 billion in

Read More
Scientists are embarking on a journey to build a plant that yields nutritious food, survives heatwaves and leaves that grow useful materials.
Climate Drugs Health

UK scientists to build world’s first artificial plant chromosome, chloroplasts

HQ Team June 12, 2025: Scientists are embarking on a journey to build a plant that yields nutritious food, survives heatwaves and leaves

Read More
Appendiceal cancer tripled in Americans born between 1976 and 1984 and quadrupled for those born between 1981 and 1989, according to a study.
Drugs Health Research

Sharp rise in appendix cancer among Gen X,  millennials in US

HQ Team June 12, 2025: Appendiceal cancer tripled in Americans born between 1976 and 1984 and quadrupled for those born between 1981 and 1989,

Read More
A machine developed by US-based HistoSonics Inc. to treat patients with primary and secondary liver tumours and other hard-to-reach tumours will be installed at the UK’s Cambridge University Hospitals later this year.
Drugs Health Pharma

UK patients to be first to get non-invasive liver cancer treatment in Europe

HQ Team June 12, 2025: A machine developed by US-based HistoSonics Inc. to treat patients with primary and secondary liver tumours and other

Read More
Novavax Inc.’s investigational vaccine that protects against both Covid-19 and seasonal flu in a single shot has generated a “strong immune response” during end-stage trials, the company stated.
Drugs Health Pharma

Novavax’s Covid-19-influenza vaccine trial yields ‘strong’ immune response

HQ Team June 12, 2025: Novavax Inc.’s investigational vaccine that protects against both Covid-19 and seasonal flu in a single shot has generated

Read More
The US Food and Drug Administration has approved Nuvation Bio Inc.’s medicine for adults who have a rare type of lung cancer caused by a specific genetic change.
Drugs Health Pharma

US drug regulator greenlights Nuvation’s rare lung cancer medicine

HQ Team June 11, 2025: The US Food and Drug Administration has approved Nuvation Bio Inc.’s medicine for adults who have a rare

Read More
Denmark’s Novo Nordisk A/S and US-based Deep Apple Therapeutics Inc. signed an $812 million agreement to develop an oral small molecule targeting cardiometabolic diseases, such as obesity.
Climate Health Research

Novo Nordisk in $812m pact with Deep Apple for oral small molecule

HQ Team June 11, 2025: Denmark’s Novo Nordisk A/S and US-based Deep Apple Therapeutics Inc. signed an $812 million agreement to develop an

Read More
Ocean acidification, a process by which the world’s oceans absorb excess carbon dioxide from the atmosphere, becoming more acidic, crossed a “planetary boundary” or safety limit five years ago, a study finds.
Climate Health Research

Ocean acidification: ‘A ticking time bomb’ for marine systems, study finds

HQ Team June 11, 2025: Ocean acidification, a process by which the world’s oceans absorb excess carbon dioxide from the atmosphere, becoming more

Read More
The US drug regulator has put on hold two trials of Gilead Sciences Inc., testing a combination of two of its investigational HIV treatments, after some patients developed lower immune cell counts.
Drugs Health Pharma

Gilead Sciences’ HIV experimental trials put on hold by US drug regulator

HQ Team June 11, 2025: The US drug regulator has put on hold two trials of Gilead Sciences Inc., testing a combination of

Read More
US President Donald Trump’s administration has sacked all 17 vaccine experts from an advisory panel to the Centers for Disease Control (CDC) and Prevention to “restore public trust.”
Drugs Health Pharma

US health secretary Kennedy fires all 17 members of vaccine advisory panel

HQ Team June 10, 2025: US President Donald Trump’s administration has sacked all 17 vaccine experts from an advisory panel to the Centers

Read More